313 related articles for article (PubMed ID: 23098325)
1. Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma.
Mansur AH; Kaiser K
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):190-9. PubMed ID: 23098325
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of fluticasone/formoterol combination therapy in patients with moderate-to-severe asthma.
Corren J; Mansfield LE; Pertseva T; Blahzko V; Kaiser K
Respir Med; 2013 Feb; 107(2):180-95. PubMed ID: 23273405
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial.
Nathan RA; D'Urzo A; Blazhko V; Kaiser K
BMC Pulm Med; 2012 Oct; 12():67. PubMed ID: 23078148
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma.
Pearlman DS; LaForce CF; Kaiser K
Clin Ther; 2013 Jul; 35(7):950-66. PubMed ID: 23870606
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial.
Bodzenta-Lukaszyk A; van Noord J; Schröder-Babo W; McAulay K; McIver T
Curr Med Res Opin; 2013 May; 29(5):579-88. PubMed ID: 23368897
[TBL] [Abstract][Full Text] [Related]
7. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
8. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
9. Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study.
Bodzenta-Lukaszyk A; Dymek A; McAulay K; Mansikka H
BMC Pulm Med; 2011 May; 11():28. PubMed ID: 21605396
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
11. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
12. A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma.
Emeryk A; Klink R; McIver T; Dalvi P
Ther Adv Respir Dis; 2016 Aug; 10(4):324-37. PubMed ID: 27185164
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
[TBL] [Abstract][Full Text] [Related]
14. Mometasone furoate/formoterol in the treatment of persistent asthma.
Berger WE
Expert Rev Respir Med; 2011 Dec; 5(6):739-46. PubMed ID: 22082160
[TBL] [Abstract][Full Text] [Related]
15. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
16. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
Aalbers R; Brusselle G; McIver T; Grothe B; Bodzenta-Lukaszyk A
Adv Ther; 2012 Nov; 29(11):958-69. PubMed ID: 23081745
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fluticasone propionate/formoterol fumarate in pediatric asthma patients: a randomized controlled trial.
Płoszczuk A; Bosheva M; Spooner K; McIver T; Dissanayake S
Ther Adv Respir Dis; 2018; 12():1753466618777924. PubMed ID: 29857783
[TBL] [Abstract][Full Text] [Related]
18. Fluticasone propionate/formoterol for COPD management: a randomized controlled trial.
Papi A; Dokic D; Tzimas W; Mészáros I; Olech-Cudzik A; Koroknai Z; McAulay K; Mersmann S; Dalvi PS; Overend T
Int J Chron Obstruct Pulmon Dis; 2017; 12():1961-1971. PubMed ID: 28740376
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
[TBL] [Abstract][Full Text] [Related]
20. Superiority of fluticasone propionate/formoterol fumarate versus fluticasone propionate alone in patients with moderate-to-severe asthma: a randomised controlled trial.
Pertseva T; Dissanayake S; Kaiser K
Curr Med Res Opin; 2013 Oct; 29(10):1357-69. PubMed ID: 23865726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
